Evidence map›Paper›PMID 40313611›Full record

ArticleFrontiers in neurology2025

Neurocysticercosis detected by targeted next-generation sequencing of cerebrospinal fluid: a case report.

Xintong Ren, HuiQin Sun, Yanghong Cheng, Yunzhou Zhang, Daiquan Gao

Abstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xintong Ren *Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
HuiQin Sun *Department of Neurology, The Fifth People's Hospital of Huai'an and the Affiliated Huai'an Hospital of Yangzhou University, Huai'an, China.
Yanghong ChengEncephalopathy Rehabilitation Department, Yixian Hospital of Traditional Chinese Medicine, Baoding, China.
Yunzhou ZhangDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Daiquan GaoDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The patient, a middle-aged male with a long history of the disease, had experienced recurrent headaches for 26 years and episodic shaking of the right limb with slurred speech for the past month. He was previously diagnosed with cerebral cysticercosis and had shown improvement after anthelmintic treatment. In recent years, he noted a resurgence of headaches. One month prior, he developed right limb shaking and occasional slurred speech. A clinical neurological examination was unremarkable, but cranial MRI and cerebrospinal fluid sequencing confirmed a diagnosis of cerebral cysticercosis. Anthelmintic treatment was administered, resulting in symptom improvement.

Indexed as

albendazolecerebrospinal fluidneurocysticercosisseizuretargeted metagenomic next-generation sequencing

Identifiers

PMID40313611
PMCPMC12043463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.